Corticosteroid Therapy for Crizotinib-induced, Allergy-mediated Liver Injury: a Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Corticosteroid Therapy for Crizotinib-induced, Allergy-mediated Liver Injury: a Case Report

Published:2015 Issue:1 Volume:55 Page:48-52
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Oonuma Hitoshi¹,Kato Jin-ichi¹,Oyama Kazuyuki²,Kawahara Ritsuko³,Seki Kunihiko⁴,Inoue Yuzuru¹

Affiliation:

1. Department of Respiratory Medicine, Shin-Yamanote Hospital, Japan Anti-Tuberculosis Association

2. Department of Radiation Therapy, Shin-Yamanote Hospital, Japan Anti-Tuberculosis Association

3. Department of Clinical Laboratory, Shin-Yamanote Hospital, Japan Anti-Tuberculosis Association

4. Department of Clinical Laboratory, JR Tokyo General Hospital

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/55/1/55_48/_pdf

Reference8 articles.

1. 1. Camidge DR, Bang YJ, Kwak EL, Iafrate AJ, Varella-Garcia M, Fox SB, et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study. Lancet Oncol. 2012; 13: 1011-1019.

2. Proposal of diagnostic criteria of drug induced hepatic injury in DDW-J2004 workshop.

3. 6. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005; 4: 489-499.

4. 8. Stern RS. Clinical practice. Exanthematous drug eruptions. N Engl J Med. 2012; 366: 2492-2501.

5. 9. Takikawa H, Murata Y, Horiike N, Fukui H, Onji M. Drug-induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006. Hepatol Res. 2009; 39: 427-431.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Adverse Effects by Molecular Targeted Therapy and Immunotherapy;Molecular Targeted Therapy of Lung Cancer;2017

2. A Case of Post-operative Recurrence ALK-positive Lung Cancer Accompanied by Liver Dysfunction and Drug Eruption Caused by Crizotinib But Not Alectinib;Haigan;2016

3. Successful Desensitization Therapy with Crizotinib for Disease-recurrence of Resected Lung Adenocarcinoma;Haigan;2016

4. Crizotinib;Reactions Weekly;2015-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3